Literature DB >> 9609805

Hypercapnia-induced long-term depression of respiratory activity requires alpha2-adrenergic receptors.

K B Bach1, G S Mitchell.   

Abstract

We investigated the effects of repeated hypercapnic episodes (inspired CO2 fraction = 0.10) on posthypercapnic respiratory nerve discharge. Anesthetized (urethan), vagotomized, and artificially ventilated rats were presented with three consecutive 5-min episodes of hyperoxic hypercapnia, separated by 5 min of hyperoxic normocapnia (inspired O2 fraction = 0.5). Respiratory nerve discharge and blood gases were recorded before and 30 and 60 min after the final hypercapnic episode. Posthypercapnia, arterial PCO2 was maintained within 1 Torr of initial baseline values. Integrated phrenic and hypoglossal burst amplitudes decreased posthypercapnia by up to 46 +/- 17 and 55 +/- 13% of baseline values, respectively, and remained reduced for at least 1 h [long-term depression (LTD)]. The protocol was repeated in rats pretreated with the alpha2-adrenergic antagonists yohimbine HCl (0.5 mg/kg; n = 7) or 2-[2-(2-methoxy-1,4-benzodioanyl)]imidazoline (RX-821002) HCl (0.25 mg/kg; n = 3). Both drugs attenuated LTD in the phrenic and hypoglossal neurograms. Results indicate that episodic hypercapnia elicits a yohimbine- and RX-821002-sensitive LTD of respiratory nerve activity in rats, suggesting that LTD requires alpha2-receptor activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609805     DOI: 10.1152/jappl.1998.84.6.2099

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

Review 1.  Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?

Authors:  Bharati Prasad; Sharmilee M Nyenhuis; Ikuyo Imayama; Aminaa Siddiqi; Mihaela Teodorescu
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

Review 2.  Hypoxia-induced changes in neuronal network properties.

Authors:  Fernando Peña; Jan-Marino Ramirez
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

3.  Altered respiratory motor drive after spinal cord injury: supraspinal and bilateral effects of a unilateral lesion.

Authors:  F J Golder; P J Reier; D C Bolser
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

4.  Simulated apnoeas induce serotonin-dependent respiratory long-term facilitation in rats.

Authors:  Safraaz Mahamed; Gordon S Mitchell
Journal:  J Physiol       Date:  2008-02-21       Impact factor: 5.182

5.  In hamsters dopamine D2 receptors affect ventilation during and following intermittent hypoxia.

Authors:  Evelyn H Schlenker
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2007-08-28       Impact factor: 2.320

Review 6.  Intermittent hypoxia induces functional recovery following cervical spinal injury.

Authors:  Stéphane Vinit; Mary Rachael Lovett-Barr; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2009-08-03       Impact factor: 1.931

Review 7.  Inactivity-induced respiratory plasticity: protecting the drive to breathe in disorders that reduce respiratory neural activity.

Authors:  K A Strey; N A Baertsch; T L Baker-Herman
Journal:  Respir Physiol Neurobiol       Date:  2013-06-28       Impact factor: 1.931

8.  Cervical dorsal rhizotomy enhances serotonergic innervation of phrenic motoneurons and serotonin-dependent long-term facilitation of respiratory motor output in rats.

Authors:  R Kinkead; W Z Zhan; Y S Prakash; K B Bach; G C Sieck; G S Mitchell
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  Blockade of alpha2-adrenergic receptors in the caudal raphe region enhances the renal sympathetic nerve activity response to acute intermittent hypercapnia in rats.

Authors:  K Madirazza; R Pecotic; I Pavlinac Dodig; M Valic; Z Dogas
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

Review 10.  Respiratory frequency plasticity during development.

Authors:  Stephen M Johnson; Karanbir S Randhawa; Tracy L Baker; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2019-05-03       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.